Top Institutions in Ophthalmology - Retinal Diseases
Leading institutions in ophthalmology and retinal disease research conduct early-phase clinical trials, translational research on angiogenesis inhibitors, and large-scale multicenter studies to evaluate novel therapeutics for nAMD. Their expertise includes advanced imaging, pharmacokinetics, and clinical trial design for retinal vascular diseases.
-
#1
Bascom Palmer Eye Institute
Miami, FL
Bascom Palmer is internationally recognized for pioneering research and clinical trials in retinal diseases including nAMD, with extensive experience in anti-VEGF therapies and novel biologics.
Key Differentiators
- Ophthalmology
- Retinal Diseases
- Clinical Trials
-
#2
Massachusetts Eye and Ear Infirmary
Boston, MA
Known for its translational research in retinal vascular biology and leadership in clinical trials of novel anti-angiogenic agents for nAMD.
Key Differentiators
- Ophthalmology
- Retinal Vascular Diseases
- Translational Research
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute has a strong history of innovation in retinal disease therapies and conducts comprehensive clinical trials in nAMD and related retinal vascular disorders.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Research
-
#4
Moorfields Eye Hospital
London, N/A
Europe’s leading eye hospital with a strong focus on retinal disease research and clinical trials, including novel biologics targeting VEGF and angiopoietin pathways.
Key Differentiators
- Ophthalmology
- Retinal Diseases
- Clinical Trials
-
#5
Singapore National Eye Centre
Singapore, N/A
A leading center in Asia for retinal disease research and clinical trials, with expertise in novel anti-angiogenic therapies and retinal imaging technologies.
Key Differentiators
- Ophthalmology
- Retinal Diseases
- Clinical Trials
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
